15 Products
In development (1) | Proposed (1)
There are 2
new
and 0
updated
products since
December 2017
NICE Pathways
Interactive topic-based flowcharts that allow you to navigate our recommendations on any subject. Find out more about NICE Pathways.
NICE guidelines
Evidence-based recommendations on a range of health and care topics. Find out more about NICE guidelines
Quality standards
Statements covering priority areas for quality improvement (including ways to measure quality). Find out more about Quality standards.
Technology appraisal guidance
Assessments of the clinical and cost effectiveness of health technologies (most commonly medicines, but also medical devices, procedures and diagnostic techniques). Find out more about Technology appraisals guidance.
-
Botulinum toxin type A for the prevention of headaches in adults with chronic migraine (TA260)
-
Tocilizumab for treating giant cell arteritis (TA518)
Interventional procedures guidance
Assessments of whether procedures are safe enough and work well enough for wider use in the NHS. Find out more about Interventional procedures guidance.
-
Deep brain stimulation for intractable trigeminal autonomic cephalalgias (IPG381)
-
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache (IPG527)
-
Occipital nerve stimulation for intractable chronic migraine (IPG452)
-
Percutaneous closure of patent foramen ovale for recurrent migraine (IPG370)
-
Transcranial magnetic stimulation for treating and preventing migraine (IPG477)
-
Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine (IPG559)
-
Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine (IPG552)
Evidence summaries
Summaries of the best available evidence for selected new medicines, off-label use of licensed medicines and unlicensed medicines. Find out more about Evidence summaries.
In development
Proposed
New guidance and advice
Guidance and advice added since December 2017